GenomicsNext™ Platform
Oncology (Multiple Tumor Types)
Development/DiscoveryActive
Key Facts
Indication
Oncology (Multiple Tumor Types)
Phase
Development/Discovery
Status
Active
Company
About GeneCentric Therapeutics
GeneCentric Therapeutics is a private, commercial-stage diagnostics company pioneering integrated liquid biopsy solutions for precision oncology. Its core innovation is the GenomicsNext™ platform, powered by proprietary ExpressCT™ technology, which infers gene expression from standard ctDNA sequencing data, adding a critical new dimension to liquid biopsies. The company has a commercial product, PurIST®, for pancreatic cancer subtyping, and is advancing its platform through strategic collaborations with biopharma and diagnostic partners to enhance drug development and clinical decision-making.
View full company profile